Tigenix, S.A.U.
Records under this name other than the patents Tigenix, S.A.U. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,186,344 | Cell Populations Having Immunoregulatory Activity, Method for Isolation and Uses Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,679,834 | Methods and Compositions for Use in Cellular Therapies Formerly held In force · High confidence | In force | High confidence | |
| US 8,999,709 | Use of Adipose Tissue-Derived Stromal Stem Cells in Treating Fistula Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,746,729 | Biomarkers for Determining the Clinical Response to Cell Therapy Formerly held In force · High confidence | In force | High confidence | |
| US 11,857,575 | Mesenchymal Stem Cell-Derived Exosomes and Their Uses Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,357,518 | Adipose Tissue-Derived Stromal Stem Cells for Use in Treating Refractory Complex Perianal Fistulas in Crohn's Disease Formerly held In force · High confidence | In force | High confidence | |
| US 11,273,182 | Adipose Tissue-Derived Stromal Stem Cells for Use in Treating Refractory Complex Perianal Fistulas in Crohn's Disease Formerly held In force · High confidence | In force | High confidence | |
| US 12,213,998 | Adipose Tissue-Derived Stromal Stem Cells for Use in Treating Refractory Complex Perianal Fistulas in Crohn's Disease Formerly held In force · High confidence | In force | High confidence | |
| US 11,660,318 | Use of Adipose Tissue-Derived Stromal Stem Cells in Treating Fistula Formerly held Term ended Term ended Jun 8, 2026 · Medium confidence | Term ended | Term ended Jun 8, 2026 | Medium confidence |
| US 9,943,550 | Cell Populations Having Immunoregulatory Activity, Method for Isolation and Uses Lapsed on the fee record Ended Apr 17, 2026 · Medium confidence | Lapsed on the fee record | Ended Apr 17, 2026 | Medium confidence |